| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5708 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2946 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1770 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1424 | 2021 |
| Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis M Bienko, CM Green, N Crosetto, F Rudolf, G Zapart, B Coull, ... Science 310 (5755), 1821-1824, 2005 | 879 | 2005 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 770 | 2021 |
| T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ... Nature medicine 27 (2), 270-278, 2021 | 632 | 2021 |
| Translesion synthesis: Y-family polymerases and the polymerase switch AR Lehmann, A Niimi, T Ogi, S Brown, S Sabbioneda, JF Wing, ... DNA repair 6 (7), 891-899, 2007 | 506 | 2007 |
| Budding yeast Rad9 is an ATP-dependent Rad53 activating machine CS Gilbert, CM Green, NF Lowndes Molecular cell 8 (1), 129-136, 2001 | 407 | 2001 |
| The budding yeast Rad9 checkpoint protein is subjected to Mec1/Tel1‐dependent hyperphosphorylation and interacts with Rad53 after DNA damage JE Vialard, CS Gilbert, CM Green, NF Lowndes The EMBO journal, 1998 | 385 | 1998 |
| Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis TG Pavey, AH Taylor, KR Fox, M Hillsdon, N Anokye, JL Campbell, ... Bmj 343, 2011 | 377 | 2011 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ... Nature medicine 27 (2), 279-288, 2021 | 360 | 2021 |
| A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease A Takeda, E Loveman, A Clegg, J Kirby, J Picot, E Payne, C Green International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2006 | 297 | 2006 |
| 53BP1 cooperation with the REV7–shieldin complex underpins DNA structure-specific NHEJ H Ghezraoui, C Oliveira, JR Becker, K Bilham, D Moralli, C Anzilotti, ... Nature 560 (7716), 122-127, 2018 | 296 | 2018 |
| A role for polymerase η in the cellular tolerance to cisplatin-induced damage MR Albertella, CM Green, AR Lehmann, MJ O'Connor Cancer research 65 (21), 9799-9806, 2005 | 289 | 2005 |
| When repair meets chromatin CM Green, G Almouzni EMBO reports, 2002 | 287 | 2002 |
| Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ... The Lancet 398 (10304), 981-990, 2021 | 285 | 2021 |
| A novel Rad24 checkpoint protein complex closely related to replication factor C CM Green, H Erdjument-Bromage, P Tempst, NF Lowndes Current Biology 10 (1), 39-42, 2000 | 270 | 2000 |
| Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival H Choudhry, A Albukhari, M Morotti, S Haider, D Moralli, J Smythies, ... Oncogene 34 (34), 4482-4490, 2015 | 261 | 2015 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... The lancet HIV 8 (8), e474-e485, 2021 | 248 | 2021 |
